Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Wolfe Research Downgrades Qualys to Peer Perform

Wolfe Research Downgrades Qualys to Peer Perform

Wolfe Research analyst Joshua Tilton downgrades Qualys (NASDAQ:QLYS) from Outperform to Peer Perform.

byBenzinga Newsdesk

February 13, 2023

1 minute read

Wolfe Research analyst Joshua Tilton downgrades Qualys (NASDAQ:QLYS) from Outperform to Peer Perform.

Chardan Capital Downgrades Moderna to Neutral, Raises Price Target to $191

By Benzinga Newsdesk

December 14, 9:54 AM

Chardan Capital analyst Geulah Livshits downgrades Moderna (NASDAQ:MRNA) from Buy to Neutral and raises the price target from $186 to $191.

MRNA

Grab’s Affordable Plans Strikes a Cord With Price Sensitive Users, Deliveries and Mobility Drives 77% Topline Growth In Q2

By Anusuya Lahiri

August 23, 9:11 AM

Grab Holdings Limited (NASDAQ: GRAB) reported second-quarter FY23 revenue growth of 77% year-on-year (81% Y/Y on a constant currency basis) to $567.0 million, beating the

GRAB

The Beauty Health Company Stock Is Plunging After-Hours – Here’s Why

By Ryan Gustafson

November 13, 6:13 PM

The Beauty Health Company (NASDAQ: SKIN) shares are trading lower in Monday's after-hours session after reporting worse-than-expected third-quarter financial results

SKIN

BP Says Has Determined Hurricane Ian No Longer Poses A Significant Threat To Gulf Of Mexico Assets

By Michael Horton

September 27, 1:06 PM

-Reuters

Wolfe Research Downgrades Qualys to Peer Perform

Related Posts

Chardan Capital Downgrades Moderna to Neutral, Raises Price Target to $191

Grab’s Affordable Plans Strikes a Cord With Price Sensitive Users, Deliveries and Mobility Drives 77% Topline Growth In Q2

The Beauty Health Company Stock Is Plunging After-Hours – Here’s Why

BP Says Has Determined Hurricane Ian No Longer Poses A Significant Threat To Gulf Of Mexico Assets